As discussed above, potential mechanisms such as hyperparathyroidism, oxidative stress, and inflammation induced by excess aldosterone might play important roles in bone loss in PA patients, while the direct role of excess aldosterone and suppressed renin–angiotensin system in bone metabolism remained to be further investigated. Here, REN is linked to hyperparathyroidism.